BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29735552)

  • 1. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
    Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
    Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
    Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
    Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA homozygosity is associated with Non-Hodgkin lymphoma.
    Roark CL; Ho BE; Aubrey MT; Anobile C; Israeli S; Phang TL; Braxton D; Ho AP; Freed BM
    Hum Immunol; 2022 Oct; 83(10):730-735. PubMed ID: 35953408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
    Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
    Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
    Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
    Tsai YY; Qu C; Bonner JD; Sanz-Pamplona R; Lindsey SS; Melas M; McDonnell KJ; Idos GE; Walker CP; Tsang KK; Da Silva DM; Moratalla-Navarro F; Maoz A; Rennert HS; Kast WM; Greenson JK; Moreno V; Rennert G; Gruber SB; Schmit SL
    Front Immunol; 2023; 14():1268117. PubMed ID: 37942321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
    Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
    PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer.
    Liu Z; Derkach A; Yu KJ; Yeager M; Chang YS; Chen CJ; Gyllensten U; Lan Q; Lee MH; McKay JD; Rothman N; Yang HI; Hildesheim A; Pfeiffer RM
    Cancer Res; 2021 Feb; 81(4):1148-1152. PubMed ID: 33272927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
    Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
    PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
    Moore A; Machiela MJ; Machado M; Wang SS; Kane E; Slager SL; Zhou W; Carrington M; Lan Q; Milne RL; Birmann BM; Adami HO; Albanes D; Arslan AA; Becker N; Benavente Y; Bisanzi S; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Canzian F; Caporaso N; Clavel J; Cocco P; Conde L; Cox DG; Cozen W; Curtin K; De Vivo I; de Sanjose S; Foretova L; Gapstur SM; Ghesquières H; Giles GG; Glenn M; Glimelius B; Gao C; Habermann TM; Hjalgrim H; Jackson RD; Liebow M; Link BK; Maynadie M; McKay J; Melbye M; Miligi L; Molina TJ; Monnereau A; Nieters A; North KE; Offit K; Patel AV; Piro S; Ravichandran V; Riboli E; Salles G; Severson RK; Skibola CF; Smedby KE; Southey MC; Spinelli JJ; Staines A; Stewart C; Teras LR; Tinker LF; Travis RC; Vajdic CM; Vermeulen RCH; Vijai J; Weiderpass E; Weinstein S; Doo NW; Zhang Y; Zheng T; Chanock SJ; Rothman N; Cerhan JR; Dean M; Camp NJ; Yeager M; Berndt SI
    J Transl Genet Genom; 2021; 5():200-217. PubMed ID: 34622145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
    Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
    Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
    Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
    Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.
    Zhong C; Gragert L; Maiers M; Hill BT; Garcia-Gomez J; Gendzekhadze K; Senitzer D; Song J; Weisenburger D; Goldstein L; Wang SS
    Leuk Lymphoma; 2019 Dec; 60(12):2899-2908. PubMed ID: 31215275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II polymorphism in Egyptian children with lymphomas.
    Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
    Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HLA variation in lymphoma aetiology and survival.
    Zhong C; Cozen W; Bolanos R; Song J; Wang SS
    J Intern Med; 2019 Aug; 286(2):154-180. PubMed ID: 31155783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.
    Kurzwelly D; Müller CA; Korfel A; Thiel E; Linnebank M; Weller M; Herrlinger U
    J Neurooncol; 2008 Oct; 90(1):53-5. PubMed ID: 18587537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.